Target Name: ZFP91
NCBI ID: G80829
Review Report on ZFP91 Target / Biomarker Content of Review Report on ZFP91 Target / Biomarker
ZFP91
Other Name(s): Zinc finger protein 757 | PZF | Zfp-91 | ZNF757 | ZFP-91 | zinc finger protein homologous to Zfp91 in mouse | Zinc finger protein homologous to Zfp91 in mouse | Zinc finger protein 91 homolog | OTTHUMP00000196613 | ZFP91 variant 1 | ZFP91 zinc finger protein, atypical E3 ubiquitin ligase | E3 ubiquitin-protein ligase ZFP91 | E3 ubiquitin-protein ligase ZFP91 (isoform 1) | ZFP91_HUMAN | zinc finger protein 757 | FKSG11 | penta zinc finger protein | DSM8 | Penta zinc finger protein | DSM-8 | DMS-8 | RING-type E3 ubiquitin transferase ZFP91 | Drug resistance-associated sequence in melanoma 8 | ZFP91 zinc finger protein, atypical E3 ubiquitin ligase, transcript variant 1 | drug resistance-associated sequence in melanoma 8 | OTTHUMP00000196612 | zinc finger protein 91 homolog

ZFP91: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. ZFP91, also known as Zinc finger protein 757, is a ZFP that is expressed in various tissues and has been identified as a potential drug target and biomarker. In this article, we will discuss the ZFP91 protein, its potential drug targeting properties, and its potential as a biomarker for various diseases.

Potential Drug Target

The ZFP91 protein is a ZFP that is characterized by the presence of a zinc finger domain. This domain is known to play a crucial role in protein-protein interactions and is involved in the regulation of various cellular processes. ZFP91 has been shown to interact with several protein partners, including the transcription factor, p53.

The zinc finger domain is also known to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. ZFP91 has been shown to be involved in the regulation of cell cycle progression, and it has been shown to play a role in the regulation of apoptosis.

In addition to its role in cellular processes, ZFP91 has also been shown to be involved in the regulation of gene expression. ZFP91 has been shown to interact with several transcription factors, including NF-kappa-B, AP-1, and STAT3. This suggests that ZFP91 may be involved in the regulation of cellular gene expression.

Potential Biomarker

ZFP91 has also been shown to have potential as a biomarker for various diseases. For example, ZFP91 has been shown to be expressed in various tissues and has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

In addition to its role in cellular processes, ZFP91 has also been shown to be involved in the regulation of gene expression. ZFP91 has been shown to interact with several transcription factors, including NF-kappa-B, AP-1, and STAT3. This suggests that ZFP91 may be involved in the regulation of cellular gene expression and may be a potential biomarker for various diseases.

Conclusion

ZFP91 is a ZFP that has been identified as a potential drug target and biomarker. Its unique zinc finger domain and its involvement in various cellular processes make it an attractive candidate for drug targeting. Further research is needed to determine the exact role of ZFP91 in cellular processes and to determine its potential as a biomarker for various diseases.

Protein Name: ZFP91 Zinc Finger Protein, Atypical E3 Ubiquitin Ligase

Functions: Atypical E3 ubiquitin-protein ligase that mediates 'Lys-63'-linked ubiquitination of MAP3K14/NIK, leading to stabilize and activate MAP3K14/NIK. It thereby acts as an activator of the non-canonical NF-kappa-B2/NFKB2 pathway. May also play an important role in cell proliferation and/or anti-apoptosis

The "ZFP91 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFP91 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZFP91-CNTF | ZFP92 | ZFPL1 | ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR | ZFR2 | ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16